FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ronan Depoortère

Research Profile

Chemicals & Drugs

Living Beings

Concepts & Ideas

Drug Dose Response Relationship

Disorders

Activities & Behaviors

Co-author Network

Publications

TOP 3
Agnès Auclair; Laurent Bardin; Didier Cussac; Peter Heusler; M Marien; J C Martel; A Newman-Tancredi; J A O'Connor; Marie-Bernadette Assié; Ronan Depoortère
Levomilnacipran (F2695), a norepinephrine-preferring SNRI: Profile in vitro and in models of depression and anxiety.
Ronan Depoortère; Mathieu Meleine; Emilie Muller; Monique Aliaga; Denis Ardid; Laurent Bardin; Adrian Newman-Tancredi
Milnacipran is active in models of irritable bowel syndrome and abdominal visceral pain in rodents.
Juan Mico; Adrian Newman-Tancredi; Olivier Vitton; Laurent Bardin; Esther Berrocoso; Philippe Ladure; Ronan Depoortère
Effects of milnacipran, duloxetine and indomethacin, in polyarthritic rats using the Randall-Selitto model.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ronan Depoortère (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Agnès Auclair; Laurent Bardin; Didier Cussac; Peter Heusler; M Marien; J C Martel; A Newman-Tancredi; J A O'Connor; Marie-Bernadette Assié; Ronan Depoortère
Levomilnacipran (F2695), a norepinephrine-preferring SNRI: Profile in vitro and in models of depression and anxiety.
Neuropharmacology 2013;70():338-47.
2011: Ronan Depoortère; Mathieu Meleine; Emilie Muller; Monique Aliaga; Denis Ardid; Laurent Bardin; Adrian Newman-Tancredi
Milnacipran is active in models of irritable bowel syndrome and abdominal visceral pain in rodents.
European journal of pharmacology 2011;672(1-3):83-7.
2011: Juan Mico; Adrian Newman-Tancredi; Olivier Vitton; Laurent Bardin; Esther Berrocoso; Philippe Ladure; Ronan Depoortère
Effects of milnacipran, duloxetine and indomethacin, in polyarthritic rats using the Randall-Selitto model.
Behavioural pharmacology 2011;22(5-6):599-606.
2011: Esther Berrocoso; Juan-Antonio Mico; Olivier Vitton; Philippe Ladure; Adrian Newman-Tancredi; Ronan Depoortère; Laurent Bardin
Evaluation of milnacipran, in comparison with amitriptyline, on cold and mechanical allodynia in a rat model of neuropathic pain.
European journal of pharmacology 2011;655(1-3):46-51.
2010: Marie-Bernadette Assié; Laurent Bardin; Agnès L Auclair; Elisabeth Carilla-Durand; Ronan Depoortère; Wouter Koek; Mark S Kleven; Francis Colpaert; Bernard Vacher; Adrian Newman-Tancredi
F15599, a highly selective post-synaptic 5-HT(1A) receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2010;13(10):1285-98.
2010: Agnès L Auclair; Adeline Cathala; Frédéric Sarrazin; Ronan Depoortère; Pier Vincenzo Piazza; Adrian Newman-Tancredi; Umberto Spampinato
The central serotonin 2B receptor: a new pharmacological target to modulate the mesoaccumbens dopaminergic pathway activity.
Journal of neurochemistry 2010;114(5):1323-32.
2010: Ronan Depoortère; Agnès L Auclair; Laurent Bardin; Francis C Colpaert; Bernard Vacher; Adrian Newman-Tancredi
F15599, a preferential post-synaptic 5-HT1A receptor agonist: activity in models of cognition in comparison with reference 5-HT1A receptor agonists.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2010;20(9):641-54.
2010: Laurent Bardin; S Gregoire; M Aliaga; N Malfetes; O Vitton; P Ladure; Adrian Newman-Tancredi; Ronan Depoortère
Comparison of milnacipran, duloxetine and pregabalin in the formalin pain test and in a model of stress-induced ultrasonic vocalizations in rats.
Neuroscience research 2010;66(2):135-40.
2009: Laurent Bardin; N Malfetes; Adrian Newman-Tancredi; Ronan Depoortère
Chronic restraint stress induces mechanical and cold allodynia, and enhances inflammatory pain in rat: Relevance to human stress-associated painful pathologies.
Behavioural brain research 2009;205(2):360-6.
2009: Agnès Auclair; Mark S Kleven; Catherine Barret-Grévoz; Martine Barreto; Adrian Newman-Tancredi; Ronan Depoortère
Differences among conventional, atypical and novel putative D(2)/5-HT(1A) antipsychotics on catalepsy-associated behaviour in cynomolgus monkeys.
Behavioural brain research 2009;203(2):288-95.
2009: Jean-Claude Martel; Marie-Bernadette Assié; Laurent Bardin; Ronan Depoortère; Didier Cussac; Adrian Newman-Tancredi
5-HT1A receptors are involved in the effects of xaliproden on G-protein activation, neurotransmitter release and nociception.
British journal of pharmacology 2009;158(1):232-42.
2009: Ronan Depoortère; Laurent Bardin; Michael Rodrigues; Erika Abrial; Monique Aliaga; Adrian Newman-Tancredi
Penile erection and yawning induced by dopamine D2-like receptor agonists in rats: influence of strain and contribution of dopamine D2, but not D3 and D4 receptors.
Behavioural pharmacology 2009;20(4):303-11.
2009: Agnès Auclair; Joël Besnard; Adrian Newman-Tancredi; Ronan Depoortère
The five choice serial reaction time task: comparison between Sprague-Dawley and Long-Evans rats on acquisition of task, and sensitivity to phencyclidine.
Pharmacology, biochemistry, and behavior 2009;92(2):363-9.
2008: Ronan Depoortère; Catherine Barret-Grévoz; Laurent Bardin; Adrian Newman-Tancredi
Apomorphine-induced emesis in dogs: differential sensitivity to established and novel dopamine D2/5-HT(1A) antipsychotic compounds.
European journal of pharmacology 2008;597(1-3):34-8.
2007: Agnès Auclair; Alexandra Galinier; Joël Besnard; Adrian Newman-Tancredi; Ronan Depoortère
Putative antipsychotics with pronounced agonism at serotonin 5-HT1A and partial agonist activity at dopamine D2 receptors disrupt basal PPI of the startle reflex in rats.
Psychopharmacology 2007;193(1):45-54.
2007: Marie-Bernadette Assié; Laurent Bardin; Agnès Auclair; Nathalie Consul-Denjean; François Sautel; Ronan Depoortère; Adrian Newman-Tancredi
F15063, a potential antipsychotic with dopamine D(2)/D(3) antagonist, 5-HT(1A) agonist and D(4) partial agonist properties: (IV) duration of brain D2-like receptor occupancy and antipsychotic-like activity versus plasma concentration in mice.
Naunyn-Schmiedeberg's archives of pharmacology 2007;375(4):241-50.
2007: Ronan Depoortère; Laurent Bardin; Agnès Auclair; Mark S Kleven; Eric P M Prinssen; Francis Colpaert; Bernard Vacher; Adrian Newman-Tancredi
F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophrenia.
British journal of pharmacology 2007;151(2):253-65.
2007: Ronan Depoortère; Agnès Auclair; Laurent Bardin; Liesbeth A Bruins Slot; Mark S Kleven; Francis Colpaert; Bernard Vacher; Adrian Newman-Tancredi
F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. III. Activity in models of cognition and negative symptoms.
British journal of pharmacology 2007;151(2):266-77.
2007: Laurent Bardin; Agnès Auclair; Mark S Kleven; Eric P M Prinssen; Wouter Koek; Adrian Newman-Tancredi; Ronan Depoortère
Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2/serotonin 5-HT1A activity: comparison with typical and atypical conventional antipsychotics.
Behavioural pharmacology 2007;18(2):103-18.
2006: Caroline Louis; Caroline Cohen; Ronan Depoortère; Guy Griebel
Antidepressant-like effects of the corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, in a DRL-72 s schedule in the rat.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(10):2180-7.
2006: Agnès Auclair; Mark S Kleven; Joël Besnard; Ronan Depoortère; Adrian Newman-Tancredi
Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(9):1900-9.
2006: Laurent Bardin; Mark S Kleven; Catherine Barret-Grévoz; Ronan Depoortère; Adrian Newman-Tancredi
Antipsychotic-like vs cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1A agonist properties.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(9):1869-79.
2005: Ronan Depoortère; Gihad Dargazanli; Genevieve Estenne-Bouhtou; Annick Coste; Christophe Lanneau; Christophe Desvignes; Martine Poncelet; Michel Heaulme; Vincent Santucci; Michel Decobert; Annie Cudennec; Carolle Voltz; Denis Boulay; Jean-Paul Terranova; Jeanne Stemmelin; Pierre Roger; Benoit Marabout; Mireille Sevrin; Xavier Vigé; Bruno Biton; Régis Steinberg; Dominique Françon; Richard Alonso; Patrick Avenet; Florence Oury-Donat; Ghislaine Perrault; Guy Griebel; Pascal Guy GEORGE; Philippe Soubrié; Bernard Scatton
Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2005;30(11):1963-85.
2004: Denis Boulay; Ronan Depoortère; C Louis; Ghislaine Perrault; Guy Griebel; Philippe Soubrié
SSR181507, a putative atypical antipsychotic with dopamine D2 antagonist and 5-HT1A agonist activities: improvement of social interaction deficits induced by phencyclidine in rats.
Neuropharmacology 2004;46(8):1121-9.